Study guide
Aneurysmal Subarachnoid Hemorrhage: Acute Resuscitation & Securing
ABPN Neurocritical Care Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Neurologic Examination & Coma Assessment in the ICU
Current Examination, Blueprint & Preparation Neurologic Examination in Critically Ill Patients Coma Evaluation & Consciousness Alterations Delirium & Toxic-Metabolic Encephalopathy in the ICU
2 Chapter 2: Cerebral Physiology & Intracranial Dynamics
Cerebral Blood Flow, Metabolism & Autoregulation Intracranial Pressure & Compliance Cerebral Edema & Herniation Syndromes
3 Chapter 3: Intracranial Hypertension & Cerebral Perfusion Management
Tiered ICP Management Protocols Hyperosmolar Therapy & Fluid Management Advanced & Refractory ICP Interventions
4 Chapter 4: Airway, Mechanical Ventilation & Pulmonary ICU Management
Emergency Airway Management & Neuro-Intubation Mechanical Ventilation Strategies in Acute Brain Injury Tracheostomy & Ventilator Weaning in Neurocritical Care Pulmonary Complications in the Neuro-ICU Obstructive Lung Disease, Pulmonary Hypertension & Bronchoscopy
5 Chapter 5: Hemodynamics, Shock & Cardiovascular Management
Hemodynamic Monitoring & Blood Pressure Targets Vasoactive Agents: Inotropes, Vasopressors & Antihypertensives Cardiac Complications of Brain Injury
6 Chapter 6: Neuropharmacology, Analgesia & Sedation
ICU Sedation & Analgesia Neuromuscular Blockade & Monitoring Propofol Infusion Syndrome & Drug Toxicities Antiseizure Drug Pharmacology in the ICU
7 Bleeding, Thrombosis & Hematologic Emergencies
Warfarin & Heparin Reversal Direct Oral Anticoagulant (DOAC) Reversal Antiplatelet Management & Platelet Dysfunction Venous Thromboembolism Prophylaxis & Management Transfusion, Coagulopathy, TMA & Cellular-Therapy Neurotoxicity
8 Chapter 8: Systemic ICU Care, Fluids, Electrolytes & Endocrine
Hyponatremia & Osmoregulation: SIADH vs Cerebral Salt Wasting Diabetes Insipidus, Hypernatremia & Endocrine Crises Critical Care Prophylaxis, Nutrition & Infection Prevention
9 Systemic Trauma & Environmental Injury
Polytrauma, Chest Injury & Abdominal Hemorrhage Burns, Electrical Injury & Hanging
10 Cardiac Emergencies & Mechanical Support
IABP, Ventricular Devices & ECMO Acute Coronary, Valvular, Rhythm & Aortic Emergencies
11 Kidney Injury, Acid–Base & Renal Replacement
Acute Kidney Injury & Renal Drug Clearance Acid–Base Disorders, Electrolytes & Renal Replacement
12 Systemic Infection & Endocrine Emergencies
Sepsis, Endocarditis & Antimicrobial Principles Thyroid, Adrenal & Dysglycemic Emergencies
13 Gastrointestinal & Hepatic Emergencies
Acute Abdomen, GI Bleeding & Abdominal Compartment Syndrome Acute Liver Failure, Cirrhosis & Hepatic Drug Effects
14 Chapter 9: Neuroimaging in the Neuro-ICU
Non-Contrast CT & CT Angiography CT Perfusion & Advanced Perfusion Imaging Magnetic Resonance Imaging in Critical Illness
15 Chapter 10: Electrophysiology & Neuromonitoring
Continuous EEG & ACNS Standardized Critical Care Terminology Invasive Neuromonitoring: ICP & External Ventricular Drains Multimodal Monitoring: PbtO2, Microdialysis & Transcranial Doppler
16 Angiography, Electrodiagnosis & CSF Analysis
Conventional Angiography & Cranial–Spinal Shunts EMG, Nerve Conduction & Acute Muscle Disease CSF Analysis: Infection, Inflammation & Hemorrhage
17 Chapter 11: Bedside Procedures, Ultrasound & Death by Neurologic Criteria
Critical Care Procedural Skills Critical Care Ultrasound & Echocardiography Determination of Death by Neurologic Criteria
18 Chapter 12: Acute Ischemic Stroke & Reperfusion Therapies
Acute Ischemic Stroke Management & Thrombolysis Endovascular Thrombectomy & Large Vessel Occlusion Malignant Hemispheric & Cerebellar Infarction
19 Chapter 13: Spontaneous Intracerebral Hemorrhage & Intraventricular Hemorrhage
Acute Intraparenchymal Hemorrhage Management Intraventricular Hemorrhage & Hydrocephalus Surgical Evacuation & Minimally Invasive Surgery in ICH
20 Chapter 14: Aneurysmal Subarachnoid Hemorrhage & Delayed Cerebral Ischemia
Aneurysmal Subarachnoid Hemorrhage: Acute Resuscitation & Securing Delayed Cerebral Ischemia & Cerebral Vasospasm Non-Aneurysmal Subarachnoid Hemorrhage & Vascular Malformations
21 Venous, Spinal & Traumatic Vascular Disease
Cerebral Venous Thrombosis & Spinal Cord Infarction Traumatic Dissection, Carotid–Cavernous Fistula & Penetrating Injury
22 Chapter 15: Traumatic Brain & Spinal Cord Injury
Severe Traumatic Brain Injury & Contusions Acute Traumatic Spinal Cord Injury & Neurogenic Shock Spine Trauma, Fractures & Cord Syndromes
23 Chapter 16: Status Epilepticus, Seizures & Neuromuscular Emergencies
Status Epilepticus: Convulsive & Non-Convulsive Refractory & Super-Refractory Status Epilepticus Acute Neuromuscular Respiratory Failure
24 Chapter 17: Post-Cardiac Arrest Care, CNS Infections & Encephalitis
Targeted Temperature Management & Post-Cardiac Arrest Care Post-Cardiac Arrest Neuroprognostication Acute CNS Infections, Encephalitis & Inflammatory Emergencies
25 Neuroinflammation & Neurooncology
Fulminant Demyelination & Autoimmune Encephalitis Brain, Spinal & Leptomeningeal Cancer Emergencies
26 Pregnancy, Transplantation & Pediatric Care
Pregnancy, Postpartum & Post-Transplant Neurologic Care Pediatric Neurocritical Care
27 Chapter 18: Neurosurgical & Perioperative Emergencies
Postoperative Neurosurgical Complications Device Complications: EVDs, Shunts & ICP Monitors Cerebral Hyperperfusion Syndrome & Post-Interventional Emergencies
28 Chapter 19: Ethics, Palliative Care & Organ Donation in the Neuro-ICU
Communication, Surrogate Decision-Making & Conflict Resolution Neuroprognostication Ethics, Withdrawal of Life Support & Palliative Care Organ Donation & Management of the Deceased Donor
Aneurysmal Subarachnoid Hemorrhage: Acute Resuscitation & Securing
Key Takeaways Explain This Topic AI
Thunderclap headache, meningismus, collapse, or a new third-nerve palsy requires urgent assessment for SAH and other vascular causes.
Modified Fisher grading combines subarachnoid blood thickness and IVH; grade 0 has neither, and grade 4 combines thick blood with IVH.
Before securing, avoid severe hypertension, hypotension, and variability; the 2023 guideline does not select one universal numeric SBP target.
Secure a ruptured aneurysm as early as feasible, preferably within 24 hours of onset; routine antifibrinolytic treatment has not improved functional outcome.
Last updated: October 2026
Aneurysmal Subarachnoid Hemorrhage: Acute Resuscitation & Securing
Aneurysmal subarachnoid hemorrhage ( a S A H aSAH a S A H ) is a catastrophic neurovascular emergency responsible for approximately 5 % 5\% 5% of all strokes but a disproportionate share of stroke-related mortality and lifelong morbidity. Approximately 85 % 85\% 85% of non-traumatic subarachnoid hemorrhages result from the rupture of an intracranial saccular ("berry") aneurysm within the subarachnoid basal cisterns. Immediate survival and long-term functional recovery hinge on rapid diagnostic triage, targeted hemodynamic resuscitation to prevent rebleeding, and emergent aneurysm securing.
- Clinical Presentation & Diagnostic Decision Rules
- The Thunderclap Headache & Clinical Manifestations
The hallmark symptom of aSAH is the sudden, excruciating "thunderclap headache"—often described by patients as the "worst headache of my life." Pathognomonically, the pain reaches peak maximum intensity in < 1 minute < 1\text{ minute} < 1 minute from onset. Associated signs and symptoms include:
Meningismus: Neck stiffness, photophobia, and positive Kernig/Brudzinski signs, which develop over hours as subarachnoid blood undergoes hemolysis, releasing irritating free hemoglobin and inflammatory cytokines into the cerebrospinal fluid ( C S F CSF CSF ).
Transient Loss of Consciousness ( L O C LOC L OC ): Occurs in up to 50 % 50\% 50% of patients at the moment of rupture, driven by an acute spike in intracranial pressure ( I C P ICP I CP ) that momentarily equilibrates with mean arterial pressure ( M A P MAP M A P ), arresting cerebral perfusion pressure ( C P P = M A P − I C P CPP = MAP - ICP CPP = M A P − I CP ).
Terson Syndrome: Intraocular, subhyaloid, or vitreous hemorrhages observed on funduscopic examination in 10 – 20 % 10\text{--}20\% 10 – 20% of patients, caused by a sudden, massive transmission of elevated ICP through the optic nerve sheath, compressing retinal venules. Terson syndrome correlates with poor clinical grade and higher mortality.
Cranial Nerve Palsies: Most characteristically a pupil-involving cranial nerve III (oculomotor) palsy (ptosis, "down-and-out" eye, dilated unreactive pupil) arising from mechanical compression by a posterior communicating artery ( P C o A PCoA PC o A ) or internal carotid artery bifurcation aneurysm.
Sentinel (Warning) Headaches: Up to 10 – 40 % 10\text{--}40\% 10 – 40% of patients experience a warning "sentinel leak" or minor hemorrhage days to weeks prior to catastrophic rupture. Sentinel headaches are frequently misdiagnosed as tension headaches, migraines, or cervical musculoskeletal strain, representing a critical missed opportunity for intervention.
The Ottawa SAH Rule
To aid emergency clinicians in ruling out SAH among alert, neurologically intact adult patients ( ≥ 15 years \ge 15\text{ years} ≥ 15 years ) presenting with an acute, non-traumatic headache peaking within 1 hour, the Ottawa SAH Rule was derived and prospectively validated. Neuroimaging is indicated if the patient exhibits one or more of the following high-risk criteria:
- Age ≥ 40 years \ge 40\text{ years} ≥ 40 years
- Neck pain or stiffness
- Witnessed loss of consciousness
- Onset during exertion
- Thunderclap headache (instant peak pain)
- Limited neck flexion on physical examination
Note
The Ottawa SAH Rule achieves near 100 % 100\% 100% sensitivity ( 99.9 % 99.9\% 99.9% ) for identifying SAH in alert patients, although specificity is modest (~ 15 % 15\% 15% ). Its clinical utility lies in preventing inappropriate discharge without diagnostic neuroimaging.
Clinical & Radiographic Grading Scales
Standardized grading at presentation is essential for risk stratification, clinical trial benchmarking, and outcome prediction.
Clinical Grading: Hunt and Hess vs WFNS
- Grade Hunt and Hess Scale WFNS Scale
- Grade 1 Asymptomatic or mild headache, slight nuchal rigidity GCS 15, no motor deficit
Grade 2 Moderate to severe headache, nuchal rigidity, cranial nerve palsy (e.g., CN III) GCS 13–14, no motor deficit
Grade 3 Confusion, lethargy, or mild focal neurological deficit GCS 13–14, with motor deficit
Grade 4 Stupor, moderate-to-severe hemiparesis, early vegetative disturbance GCS 7–12, with or without motor deficit
Grade 5 Deep coma, decerebrate posturing, moribund appearance GCS 3–6, with or without motor deficit
Note on Hunt and Hess Grade Ia: Patients with no acute meningeal or brain reaction but presenting with a fixed focal deficit are historically classified as Grade Ia.
Radiographic Grading: The Modified Fisher Scale
The original Fisher scale (1980) had a major limitation: Grade 4 (defined as IVH or parenchymal clot with little/no cisternal blood) paradoxically exhibited a lower risk of delayed cerebral ischemia ( D C I DCI D C I ) than Grade 3 (thick cisternal clot without IVH). The Modified Fisher Scale (Frontera et al.) resolved this anomaly by establishing an ordinal gradient combining cisternal blood thickness and intraventricular hemorrhage ( I V H IVH I V H ):
- Modified Fisher Grade Non-Contrast Head CT Criteria Risk of Symptomatic Vasospasm / DCI
- Grade 1 Minimal / thin focal subarachnoid blood ( < 1 mm < 1\text{ mm} < 1 mm ), no IVH Low (~ 24 % 24\% 24% )
Grade 2 Minimal / thin focal subarachnoid blood ( < 1 mm < 1\text{ mm} < 1 mm ), with IVH Intermediate (~ 33 % 33\% 33% )
Grade 3 Thick cisternal subarachnoid blood ( ≥ 1 mm \ge 1\text{ mm} ≥ 1 mm in basal cisterns), no IVH High (~ 34 – 35 % 34\text{--}35\% 34 – 35% )
Grade 4 Thick cisternal subarachnoid blood ( ≥ 1 mm \ge 1\text{ mm} ≥ 1 mm ), with IVH Highest (~ 40 – 45 % 40\text{--}45\% 40 – 45% )
Important
Modified Fisher Grades 3 and 4 carry the highest risk of delayed cerebral ischemia and cerebral vasospasm due to the heavy volume of erythrocyte breakdown and oxyhemoglobin clearance within the basal cisterns.
- Emergency Resuscitation & Ultra-Early Medical Management [ Acute Aneurysmal SAH Diagnosis Confirmed ]
- │
- ┌──────────────┴──────────────┐
- ▼ ▼
- [ Hemodynamic Control ] [ Hydrocephalus / ICP ]
- Avoid severe hypertension and hypotension • Emergent EVD for acute
- Minimize variability; individualize pressure goal ventriculomegaly/stupor
- Avoid hypotension: • Gradual drainage at
- Maintain CPP > 60-70 mmHg 15-20 cmH2O to prevent
- First-line: IV Nicardipine, transmural rupture spike
- Clevidipine, or Labetalol
- │ │
- └──────────────┬──────────────┘
- ▼
- [ Emergent Aneurysm Securement Mandate ]
- Target obliteration as soon as feasible (< 24 hours)
- Multidisciplinary Coiling vs Clipping Selection
- Routine antifibrinolytic therapy is not recommended
- Pressure, Rebleeding, and Antifibrinolytics
Before securing, monitor frequently and use short-acting treatment to avoid severe hypertension, hypotension, and pressure variability. The 2023 AHA/ASA guideline does not establish one universal SBP target such as 160 mm Hg. Some institutions use a local ceiling, but it must be identified as a protocol choice and balanced against cerebral perfusion, hydrocephalus, and systemic circumstances.
Secure the ruptured aneurysm as early as feasible, preferably within 24 hours of onset, using a multidisciplinary choice of coiling or clipping. Prompt transfer and treatment are more important than an invented guarantee that a drug makes a prolonged delay safe.
Routine antifibrinolytic therapy does not improve functional outcome and is not recommended as routine care in the 2023 guideline. ULTRA did not show improved six-month outcome with ultra-early short-course TXA. Do not claim that it proved a significant excess of DCI and VTE as the explanation, or teach an automatic TXA transport regimen as current guideline-standard treatment. Exceptional circumstances require the treating neurovascular team's judgment.
Acute Hydrocephalus & External Ventricular Drain (EVD) Management
Acute obstructive hydrocephalus develops in 20 – 30 % 20\text{--}30\% 20 – 30% of patients due to erythrocyte and fibrin clogging of the arachnoid villi and fourth ventricular outflow tracts. In lethargic or comatose patients (Hunt and Hess Grade III–V) with ventriculomegaly on CT, an emergent EVD must be placed.
Warning
Rapid over-drainage of CSF via an EVD prior to aneurysm securing abruptly drops ICP, causing a dramatic surge in transmural pressure across the unruptured aneurysm dome ( T M P = M A P − I C P TMP = MAP - ICP TMP = M A P − I CP ) and precipitating fatal intraprocedural re-rupture. Set the EVD transducer at 15 – 20 cmH 2 O 15\text{--}20\text{ cmH}_2\text{O} 15 – 20 cmH 2 O initially to allow gradual, controlled decompression.
- Aneurysm Securing: Timing & Modality Selection
- Timing: The 24-Hour Imperative
The 2023 AHA/ASA Guidelines state that ruptured aneurysms should be secured as soon as feasible, preferably within 24 hours 24\text{ hours} 24 hours of onset (Class 1, Level B-NR) . Securing the aneurysm accomplishes two vital objectives: (1) it eliminates the threat of fatal rebleeding, and (2) it permits the safe implementation of induced hypertension and hemodynamic augmentation if delayed cerebral ischemia subsequently develops.
Endovascular Coiling vs Microsurgical Clipping: Clinical Trial Evidence
Parameter Endovascular Coiling Microsurgical Clipping
Mechanism Transfemoral/transradial microcatheter platinum coil packing ± \pm ± stent/balloon assistance Craniotomy, sylvian/subarachnoid dissection, clip closure across aneurysm neck
Pivotal Trial Evidence ISAT (International Subarachnoid Aneurysm Trial): 2,143 patients; 1-year dependency or death significantly lower with coiling (2005 one-year report: 23.5% versus 30.9%; absolute reduction 7.4 percentage points, relative reduction approximately 24%) BRAT (Barrow Ruptured Aneurysm Trial): Early functional benefit for coiling; clipping showed superior durable obliteration at 3- and 10-year follow-ups
Long-Term Durability Higher rate of incomplete occlusion and late recurrence; re-treatment rate ~ 17.4 % 17.4\% 17.4% Superior long-term complete obliteration; re-treatment rate ~ 3.8 % 3.8\% 3.8%
Invasive Morbidity Lower peri-procedural morbidity; no craniotomy, brain retraction, or cosmetic defect Higher initial surgical morbidity, prolonged recovery, seizure risk
Anatomical and Clinical Modality Selection
Factors Favoring Endovascular Coiling:
Ruptured anterior circulation aneurysms equally amenable to both modalities (ISAT cohort)
Basilar apex and posterior circulation aneurysms (PICA, vertebrobasilar junction), where surgical access carries high brainstem/cranial nerve morbidity
- Elderly patients ( > 65 years > 65\text{ years} > 65 years ) and patients with severe medical comorbidities
- Poor clinical grade (WFNS 4–5, Hunt and Hess IV–V), to minimize secondary surgical trauma
Factors Favoring Microsurgical Clipping:
Middle Cerebral Artery ( M C A MCA MC A ) bifurcation aneurysms: Favorable superficial anatomy; complex branching vessels frequently arise from the aneurysm neck, risking branch occlusion with endovascular techniques
Wide-neck aneurysms or dome-to-neck ratio < 1.5 < 1.5 < 1.5 not amenable to standard coiling without dual antiplatelet therapy ( D A P T DAPT D A PT )-requiring stents
Associated large intraparenchymal hematoma ( > 50 mL > 50\text{ mL} > 50 mL ) causing significant mass effect and brain herniation, where emergent craniotomy allows simultaneous clot evacuation, decompression, and aneurysm clip ligation